Indegene Ltd (INDGN) - Total Assets
Based on the latest financial reports, Indegene Ltd (INDGN) holds total assets worth Rs35.76 Billion INR (≈ $386.70 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Indegene Ltd's book value for net asset value and shareholders' equity analysis.
Indegene Ltd - Total Assets Trend (2020–2025)
This chart illustrates how Indegene Ltd's total assets have evolved over time, based on quarterly financial data.
Indegene Ltd - Asset Composition Analysis
Current Asset Composition (March 2025)
Indegene Ltd's total assets of Rs35.76 Billion consist of 76.1% current assets and 23.9% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 11.3% |
| Accounts Receivable | Rs7.51 Billion | 22.6% |
| Inventory | Rs0.00 | 0.0% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs1.86 Billion | 5.6% |
| Goodwill | Rs3.56 Billion | 10.7% |
Asset Composition Trend (2020–2025)
This chart illustrates how Indegene Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see INDGN market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Indegene Ltd's current assets represent 76.1% of total assets in 2025, an increase from 69.6% in 2020.
- Cash Position: Cash and equivalents constituted 11.3% of total assets in 2025, down from 29.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 12.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 22.6% of total assets.
Indegene Ltd Competitors by Total Assets
Key competitors of Indegene Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
DocCheck AG
XETRA:AJ91
|
Germany | €53.98 Million |
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
Indegene Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.96 | 4.49 | 2.80 |
| Quick Ratio | 4.96 | 5.90 | 2.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs21.81 Billion | Rs17.80 Billion | Rs7.80 Billion |
Indegene Ltd - Advanced Valuation Insights
This section examines the relationship between Indegene Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.79 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 30.7% |
| Total Assets | Rs33.26 Billion |
| Market Capitalization | $1.30 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Indegene Ltd's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Indegene Ltd's assets grew by 30.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Indegene Ltd (2020–2025)
The table below shows the annual total assets of Indegene Ltd from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs33.26 Billion ≈ $359.68 Million |
+30.65% |
| 2024-03-31 | Rs25.46 Billion ≈ $275.30 Million |
+15.51% |
| 2023-03-31 | Rs22.04 Billion ≈ $238.34 Million |
+62.83% |
| 2022-03-31 | Rs13.53 Billion ≈ $146.37 Million |
+127.08% |
| 2021-03-31 | Rs5.96 Billion ≈ $64.46 Million |
-0.70% |
| 2020-03-31 | Rs6.00 Billion ≈ $64.91 Million |
-- |
About Indegene Ltd
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more